Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perrigo Haunted By Mylan Rejection As Securities Fraud Complaints Mount

Executive Summary

Securities fraud complaint filed by Nationwide Mutual Funds alleges firm misled investors to fend off Mylan hostile takeover in 2015 before its share price began plummeting. It is latest of similar complaints filed against Perrigo in New Jersey federal court.


Related Content

Perrigo Pivots To 'Self Care' For 'Massive Opportunity' Beyond OTC Drugs
Perrigo Moves From Health Care To 'Self Care'
Perrigo Moves From Health Care To 'Self Care'
Another Change At Perrigo Helm As Results Remain Turbulent
Perrigo Looks To Spin Out Or Sell Off Rx Business, But Will Separating Generics Add Value?
Perrigo's OTC Core Could Expand To Include National Brands
Shareholders Challenge Perrigo's Defense Against Mylan Offer Two Years Earlier
Perrigo Shareholder Lawsuits Claim Joining Mylan Was A Better Idea
Perrigo Stands Alone At Top OF OTC Private Label Market, In Hunt For More Deals


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts